ALT Internship opportunity for healthcare fundraising

ALT The recent meeting of the INPHOG Liver Tumor Sub-Committee brought together investigators from across the country with a shared goal of generating high-quality evidence to improve outcomes for children with liver tumors. The meeting featured discussions on several important collaborative research initiatives: 🔹 Retrospective Indian Pediatric Liver Tumors Study - Dr Priyakumari T 🔹 Prospective Study on Liver Tumors - Dr Dhaarani J 🔹 Profile and Outcomes of Living Donor Liver Transplantation (LDLT) for Hepatoblastoma – Dr Shweta Bansal 🔹 Relapsed/Refractory Hepatoblastoma Study – Dr Badira Parambil 🔹 Role and Efficacy of Intra-arterial Chemotherapy – Dr Badira Parambil A heartfelt thank you to all presenters, investigators, and participating centers for their commitment to advancing pediatric liver tumor research in India. Together, we are building the evidence that will shape future standards of care.

ALT On World Clinical Trials Day, we recognise the power of clinical research in transforming outcomes for children with cancer and blood disorders. At INPHOG, clinical trials are pathways to safer treatments, better survival, and improved quality of life for children across India. Every protocol, every data point, and every collaboration contributes to building evidence-based pediatric hematology-oncology care that is accessible, ethical, and impactful. Over the years, INPHOG’s multicentric collaborative research efforts have helped strengthen clinical research culture across India, bringing together clinicians, researchers, institutions, and families with one shared goal of improving the lives of children fighting cancer and blood disorders. Today, we also acknowledge the courage of patients and families who participate in clinical research, and the dedication of healthcare professionals, researchers, data managers, and collaborators who make these advances possible.